Drug Approval Package

 Neulasta (Pegfilgrastim) Injection
Company:  Amgen, Inc.
Application No.:  125031
Approval Date: 1/31/2002

• Approval Letter(s) (PDF)

• Printed Labeling (PDF)

• Medical Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)  
  Part 3 (PDF)  

• Chemistry Review(s) (PDF)

• Pharmacology Review(s) (PDF)  

• Statistical Review(s) (PDF)

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)  

Date created: October 252004

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.